The French national breast screening program is to be “radically revised”
Reduction in breast cancer deaths is due to treatment not screening, finds study, The BMJ, 355/bmj.i5544/rr-1, 13 October 2016.
In view of controversies surrounding the effectiveness and consequences of breast screening, the French Minister for Health asked the French National Cancer Institute (INCa) to organize a broad public and scientific consultation on breast cancer screening. During one year, all stakeholders on breast screening ranging from citizens, patient organisations and charities to health professionals, screening experts, and governmental institutions had an opportunity to express their opinion on the benefits and on the harms of breast screening as well as on the way this screening is organised in France. The consultation report was publicly available on September 30th, 2016.
The consultation report concludes that there is no scientific consensus about the benefits and risks of mammographic screening. It regrets the absence of sound epidemiological studies on the impact of breast screening in France. It expresses deep concerns about the . . .